Background. Transudative pleural effusions due to pleuroperitoneal communication occur in 1.6-10% of patients receiving peritoneal dialysis (PD) and usually have overtly elevated glucose concentrations. Methods. We report two cases of verified pleuroperitoneal communication with minimally elevated pleural fluid glucose levels. We reviewed the literature of all PD patients with pleuroperitoneal communication that reported pleural glucose levels to assess their clinical and laboratory features and pleural fluid-to-serum glucose gradients. Results. We evaluated a total of 47 reported patients on PD with diagnosed pleuroperitoneal communication. Onset of the transudative pleural effusion after initiating PD was <3 months in only 48%. Shortness of breath was reported in 96%. Pleural effusions were right sided in 87%. Pleural fluid-to-serum glucose gradients varied from 2 to 1885 mg/ dL, with 20% 50 mg/dL, 13% being 51-100 and 67% >100 mg/dL. All pleural fluid-to-serum glucose ratios were >1.
Introduction
Peritoneal dialysis (PD) is an established effective renal replacement therapy for patients with end-stage renal disease (ESRD). An uncommon complication is hydrothorax due to pleuroperitoneal communication which occurs in
Case reports

Case 1
A 59-year-old woman with ESRD due to hypertension (HTN) presented with shortness of breath, dyspnea on exertion and right chest pressure radiating to the jaw for 1 day. She had been started on continuous ambulatory peritoneal dialysis (CAPD) 3 days before presentation. She had no history of abdominal trauma, endometrial or malignant implants on the diaphragm or surgery involving the diaphragm but did have prior pregancies. Physical findings disclosed a blood pressure of 142/87 mmHg, a pulse rate of 89 beats/min and respiration rate of 20/min. Chest exam revealed decreased breath sounds bilaterally, without any crackles or wheezing. Chest radiography showed new bilateral pleural effusions, right greater than left. Right thoracocentesis was performed and pleural fluid analysis showed clear yellow fluid with 143 nucleated cells, neutrophils of 3%, lymphocytes of 24% and some mesothelial cells. Fluid amylase was 31 U/L, glucose was 127 mg/dL (blood glucose was 107 mg/dL at the same time) and protein was 0.4 g/dL. Because the effusion was transudative and pleural fluid-to-serum glucose gradient was only 20 mg/dL, scintigraphy was performed as follows. All fluid was drained from the abdomen. Then, 3.8 mCi of Tc-99m sulfur colloid, the dose and radionuclide used to assess pleuroperitoneal communications in patients with ascites, was injected into the peritoneal catheter followed by infusion of 2 L of 2.5% dextrose dialysate fluid. Images of the chest and the abdomen were obtained at 5-min intervals for 1 h. Within 5 min, tracer was seen above the diaphragm in both thoracic cavities, significantly greater on the right than left, with 10% of the total dose in the thorax after 40 min (Figure 1a) . After discontinuing the PD and starting hemodialysis, a follow-up chest radiography showed resolution of both pleural effusions. The patient's clinical symptoms resolved completely. The hydrothorax did not contribute to the patient's demise, which occurred several years later due to an unknown cause.
Case 2
A 56-year-old female with a history of ESRD due to diabetes mellitus (DM) Type 1 for 42 years, on CAPD for 2 months, presented with progressive shortness of breath and fatigue for 1 day prior to admission. She had no history of abdominal trauma, multiparity, endometrial or malignant implants on the diaphragm or surgery involving the diaphragm. Physical examination showed a blood pressure of 166/66 mmHg, a pulse rate of 79 beats/min, respiratory rate of 20/min and diminished breath sounds over the right 2/3 of both lower lung fields, with scattered fine crackles. Chest radiography showed a new right pleural effusion, in addition to a previous left pleural effusion. Right-sided thoracocentesis showed pleural fluid with red blood cell count of 1092/cm 3 , white blood cell count of 37/cm 3 , neutrophils 30%, monocytes 70% and glucose 314 mg/dL. Blood glucose at the same time was 264 mg/dL. Pleural fluid Lactate dehydrogenase was 45 IU/ L and total protein was 0.3 g/dL. Because the effusion was a transudate and pleural fluid-to-serum glucose gradient was only 50 mg/dL, peritoneal scintigraphy was performed as described in Case 1. Accumulation of isotope activity was evident within 10 min, with 10% in the right pleural area within 40 min, confirming a pleuroperitoneal communication. After discontinuing PD and starting hemodialysis, symptoms resolved and a follow-up chest radiography showed resolution of the right pleural effusion. The right hydrothorax did not contribute to the subsequent demise which occurred several years later due to bowel infarction and sepsis. Figure 1b shows a negative scintigraphy study in a patient with cirrhosis and ascites suspected to have a pleuroperitoneal communication as the cause of his transudative right pleural effusion. After injection of Tc-99m sulfur colloid, there was no tracer detected above the diaphragm after 75 min, indicating that a pleuroperitoneal communication was not the cause of the pleural effusion.
Institutional Review Board approval was not required because these patients subsequently expired.
Review of the literature
We reviewed the literature up to April 2011 and found 45 cases with pleuroperitoneal communication in patients undergoing PD with pleural fluid glucose levels or gradients reported. Table 1 lists these cases of pleuroperitoneal communication with pleural glucose levels reported in the literature and the pertinent findings [2, 4, 7, [9] [10] [11] [12] [13] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] . We divided the patients into four groups based on the PF-S glucose gradients. Patients were arbitrarily divided into those with PF-S glucose gradient 50 mg/dL as low gradient, 51-100 mg/dL as moderate gradient and >100 mg/dL as high gradient. In seven cases of pleuroperitoneal communication, the glucose levels in both pleural fluid and serum were not reported. We included these cases to show the high pleural glucose concentrations in all these cases. Our two cases are included with six other cases of low gradient pleuroperitoneal communication in PD patients. The reported cases in Table 1 are listed from the lowest to the highest PF-S glucose gradient values. Table 2 summarizes the main findings for the total group. Our two patients were similar to the other patients. Of the 47 cases, 62% were females, with a median age of 52 years. Causes of ESRD were DM in 11%, HTN in 11% and glomerulonephritis in 23%. The most common clinical presentations were shortness of breath in 96%. Some pleural effusions were asymptomatic and detected by routine chest radiography [5] . All patients with pleuroperitoneal communication had new onset transudative pleural effusions by chest radiography after starting PD. In 48% of patients, pleural effusions developed within 3 months after starting CAPD. In 18%, the pleural effusion was detected after 3-6 months and in 34% after 6 months of PD. Pleural effusions were right sided in 87%. Pleuroperitoneal communication was definitively diagnosed by scintigraphy in 38%, as in our two cases, or by video-assisted thoracoscopic surgery (VATS) (34%), with 9% diagnosed by high PF-S glucose gradients of 165, 176, 734 and 1885 mg/dL, respectively. None of the latter four patients had DM. Treatment for pleuroperitoneal communication included stopping CAPD in 28% and VATS with or without pleurodesis in 36%.
Discussion
A high PF-S glucose gradient >100 mg/dL is believed to be highly suspicious or even diagnostic of pleuroperitoneal communication in patients receiving CAPD [13, 14] and was present in 67% of reported patients. A moderate PF-S glucose gradient between 50 and 100 mg/dL has been considered suggestive of pleuroperitoneal communication in patients receiving CAPD [6, 8] and was present in 13% of confirmed cases. Our two cases plus six patients from the literature with independently verified pleuroperitoneal communication had a low PF-S glucose gradient of 50 mg/dL, indicating a frequency of 20%. Thus, we concluded that any PF-S glucose gradient in PD patients with transudative pleural effusions is consistent with pleuroperitoneal communication, particularly in the absence of uncontrolled DM.
Another way of expressing this gradient would be as a pleural fluid-to-serum (PF/S) glucose ratio, which was >1 in all instances (Tables 1 and 2 ). In contrast, this ratio is 1 in non-PD transudative effusions and <0.5 in exudative effusions due to cancer, tuberculosis and rheumatoid arthritis [32] . Further, the pleural fluid glucose in cirrhotic patients with transudative effusions due to pleuroperitoneal communication is similar to serum, resulting in a PF/S glucose ratio of 1 [3] . We have clearly shown that a glucose gradient of >2 mg/dL or a ratio >1 may have a sensitivity of 100% (Tables 1 and 2 ), in contrast to the previous 
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Presentation of two cases and a review of the literatureconclusion that only a glucose gradient >50 mg/dL had a sensitivity of 100% [8] .
It has been postulated that peritoneal fluid may enter the pleural cavity in patients on PD or those with cirrhosis and ascites through diaphragmatic defects or via subdiaphragmatic lymphatics [8, 17, 29] . If the patient had a diaphragmatic defect(s), the isotope would enter the pleural cavity early and rapidly after isotope injection [17] , as in our two cases (Figure 1a) . In contrast, movement of fluid from the peritoneal to the pleural space by subdiaphragmatic lympatics would be expected to be slow and occur later after the isotope injection [17] . The relative frequency of the two mechanisms is unknown.
Since peritoneal dialysate fluid entered the pleural space rapidly in large quantities in our two scintigraphy studies (10% in 40 min), we expected the pleural fluid may have a very high glucose concentration compared to serum. Since the 2.5% peritoneal dialysate contains 2500 mg/dL dextrose and 2270 mg/dL of glucose, 1.5% contains 1500 mg/dL dextrose and 4.25% contains 4250 mg/dL dextrose, any dialysate fluid moving from the peritoneum to the pleural space through a diaphragmatic defect shortly after installation in the peritoneum would be expected to have a higher glucose concentration than serum [5, 13] . However, pleural glucose levels were 20 and 50 mg/dL greater than serum levels, with ratios of 1.18 and 1.19, in our two patients, and varied from 2 to 1885 mg/dL, with ratios of 1.01-14 in the other 38 cases (Table 1) . Pleural fluid glucose concentrations could be affected by the size of the pleuroperitoneal communication, the rate of fluid movement between compartments which depends on pleuroperitoneal pressure gradient [6] and posture, the glucose concentration in the dialysate at the time of the tap, the rate of glucose absorption from the pleural fluid with time [6, 7] and dilution by pre-existing pleural effusions. Thus, there are several possible explanations for low PF-S glucose gradient in some pleural effusions with pleuroperitoneal communication. These possibilities are discussed below.
First, a very small diaphragmatic defect or entrance of pleural fluid via the subdiaphragmatic lymphatics would result in a small volume and slow exchange of the pleural with the PD fluid [17] and may allow enough time for pleural reabsorption of glucose [6, 10, 11] . The pleural parenchyma actively absorbs glucose as illustrated by the patient with DM who had very high serum glucose levels, with a pleuroperitoneal communication that resolved when PD was discontinued [16] . In our patients, the entrance of PD fluid plus isotope was 10% in 40 min and is unlikely to be explained by these mechanisms (Figure 1a) .
Second, posture may play a role. Movement of fluid through the pleuroperitoneal communication from the peritoneum to the pleural cavity may be low if the patient is upright after the dialysate exchange and prior to the thoracentesis, during which fluid movement from the pleural space to the peritoneum may be increased. In contrast, the fluid movement into the pleura could be much higher when the patient is supine, as during scintigraphy. Thus, the rapid and large movement of isotope from the peritoneum to the pleural space in our patients may be due to their supine position during the study.
Third, patients with DM frequently have fluctuating serum glucose levels during the day, which could affect the PF-S glucose gradient [24] . A rise in serum glucose could have accounted for the low PF-S glucose gradient of 50 and PF/S ratio of 1.19 in our second patient although serum glucose at the time of the pleural tap was 264 mg/dL, while pleural fluid glucose was 314 mg/dL. In one reported case [22] , serum glucose was 609 mg/dL, while pleural fluid glucose was 822 mg/dL resulting in a PF-S glucose gradient of 213 mg/dL and a PF/S glucose ratio of 1.34. Fourth, glucose in peritoneal dialysate is reabsorbed progressively from the peritoneum during the dwell time [33] . If the pleural tap was done many hours after the last PD exchange [7] , peritoneal fluid glucose concentrations may have been much lower than the original PD solution (range: 386-940 mg/dL in nine reported cases) ( Table 1 ). The duration of the peritoneal fluid dwell time prior to the pleural tap is unknown for our two cases and for most of the reported cases. In one reported case, the thoracentesis was performed >24 h after the prior dialysate exchange accounting for a PF-S glucose gradient of 30 mg/dL [7] . Pleural glucose reabsorption is probably also continuous so pleural fluid may have a glucose concentration much less than the PD solution but higher than serum. These mechanisms may be the most likely explanation for the low PF-S glucose gradient in our patients. These variables also may explain the large differences in PF-S glucose gradients reported in patients with pleuroperitoneal communication. Use of icodextrin, which does not contain glucose, for the peritoneal dialysate could also result in a low PF-S glucose gradient but neither our patients nor those reported were using icodextrin.
With these possibilities in mind, the goal should be to standardize the PF-S glucose gradient and PF/S glucose ratio by controlling the variables. Ideally, the pleural tap should be done when the patient is fasting particularly in diabetics, using 4.25% dextrose for the dialysate to maximize the glucose concentration in the peritoneal and pleural fluid, within 1 h of the last PD exchange when the peritoneal glucose concentration is still high, and with the patient remaining supine after the exchange so that the movement of peritoneal fluid into the pleural cavity is enhanced prior to the thoracentesis, which would be done in the seated position. This should maximize the PF-S glucose gradient and PF/S glucose ratio and thus improve the diagnostic accuracy of the test (Figure 2 ). In addition, standardizing the procedure may minimize the variability of the gradient from one patient to another and allow some assessment of the size of the defect and rate of PD fluid entry into the pleural cavity.
As shown in Figure 2 , a pleural tap is necessary to differentiate a transudative from an exudative effusion in PD patients with a pleural effusion and may also indicate a pleuroperitoneal communication in those with a transudative effusion. If the PF/S glucose ratio is >1, a pleuroperitoneal communication is highly likely, except perhaps in diabetic patients whose serum glucose levels may fluctuate, and no further work-up may be necessary. If the PF/S glucose ratio is 1 or less but clinical suspicion of pleuroperitoneal communication remains high, scintigraphy would be expected to confirm or refute the diagnosis. Scintigraphy is costly, time consuming and requires another procedure with radiation exposure to the patient [6, 10] . If performed, scintigraphy should be standardized by removing as much PD fluid from the abdomen as possible followed by isotope injection into the PD catheter and subsequent installation of 2 L of PD fluid while the patient is supine and being scanned.
Conclusion
Any transudative pleural fluid glucose concentration greater than that of serum (pleural fluid to serum glucose ratio >1) in a patient receiving PD is consistent with a pleuroperitoneal communication since all other causes of transudative pleural effusions have similar or lower glucose concentrations in the pleural fluid than in serum with ratios of 1 or less. Only in questionable cases should scintigraphy be used to confirm the diagnosis of a pleuroperitoneal communication.
